ISRG Intuitive Surgical NASDAQ $471.91 pre-market 25 Mar 2026: AI upside

ISRG stock trades at $471.91 pre-market on 25 Mar 2026, down 1.28% from yesterday. The move follows mixed flows: institutional buying in the fourth quarter offset by recent insider selling and a cluster of analyst price target revisions. Intuitive Surgical, Inc. (NASDAQ: ISRG) remains a core robotics pick inside the broader AI stocks theme because its da Vinci and Ion platforms can adopt more machine learning-led features. We break down valuation, technicals, analyst views and a model-based forecast to show where ISRG stock may head next

ISRG stock price and technicals

ISRG stock is quoted at $471.91 pre-market on NASDAQ with volume 1,233,218 and average volume 1,867,700. Short-term momentum is weak: RSI 38.05, MACD -7.83, ADX 32.47 indicating a strong trend to the downside. The 50-day average is $505.85 and the 200-day average is $509.44, both above the current price, pointing to short-term technical pressure.

ISRG stock fundamentals and valuation

Intuitive Surgical, Inc. trades in the United States market with market cap $167.59 billion, EPS 7.89, and P/E 59.81. Revenue per share is 28.36 and free cash flow per share is 7.02, supporting strong margins but a stretched valuation versus peers. Meyka AI rates ISRG with a score out of 100: 79.88 (B+, BUY). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Investors should weigh premium multiples against durable cash flow and low net debt.

ISRG stock and AI-driven growth opportunities

ISRG stock sits at the intersection of robotics and AI, with da Vinci and Ion as the primary growth engines. Management’s R&D intensity (R&D/revenue ~13.03%) and growing instrument attach rates support long-term revenue per system. Sector tailwinds for AI-enabled automation could lift adoption rates, but tangible revenue depends on hospital capital budgets and reimbursement dynamics.

ISRG stock analyst sentiment and insider moves

Wall Street shows a moderate buy consensus with an average target near $614.95 and mixed target updates this quarter. Recent filings show large funds adding or trimming positions while insiders sold 32,943 shares worth about $17.28 million in the last quarter. Market reaction combines confidence from analyst upgrades with caution after insider sales and target trims.

ISRG stock risks and near-term trading strategy

Key risks for ISRG stock include valuation compression, slower hospital capital spending, and execution on new product rollouts. Volatility metrics show ATR 12.89 and Bollinger lower band $467.31, signaling downside sensitivity. Active traders should watch support near $468.36 (day low) and consider position sizing against a longer-term allocation tied to AI robotics exposure.

Final Thoughts

Key takeaways: ISRG stock trades at $471.91 pre-market on 25 Mar 2026 with stretched multiples (P/E 59.81) but strong cash flow and durable margins. Analyst consensus remains a Moderate Buy with average target $614.95, while Meyka AI’s models show further upside. Meyka AI’s forecast model projects a 12-month target of $585.45, implying an upside of 24.07% versus the current price of $471.91. Forecasts are model-based projections and not guarantees. For AI stocks exposure, Intuitive Surgical blends defensible market position and an AI-friendly product roadmap, but investors should balance valuation risk with long-term growth potential. For quick reference and alerts, see our ISRG page on Meyka AI-powered market analysis platform Meyka ISRG page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.